We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Kimco Realty
KIM
$17.7B
| $2.55M | 0.01% |
138,660
+22,800
| +20% | +$481K |
|
702
MSCI
MSCI
$42.5B
| $2.53M | 0.01% |
6,003
-3,148
| -34% | -$1.44M |
|
703
Teradata
TDC
$2.89B
| $2.53M | 0.01% |
81,439
-14,205
| -15% | -$496K |
|
|
SWAV
704
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.52M | 0.01% |
9,080
| – | – |
|
705
Lennox International
LII
$15.2B
| $2.52M | 0.01% |
11,315
-3,455
| -23% | -$822K |
|
|
IAS
706
DELISTED
Integral Ad Science
IAS
| $2.52M | 0.01% |
347,840
-30,000
| -8% | -$268K |
|
|
CIVI
707
DELISTED
Civitas Resources
CIVI
| $2.5M | 0.01% |
43,650
+31,920
| +272% | +$1.88M |
|
708
Packaging Corp of America
PKG
$22.4B
| $2.5M | 0.01% |
22,291
+2,920
| +15% | +$395K |
|
709
Travel + Leisure Co
TNL
$4.76B
| $2.5M | 0.01% |
73,385
-16,235
| -18% | -$687K |
|
710
RenaissanceRe
RNR
$13.9B
| $2.5M | 0.01% |
17,817
-10,180
| -36% | -$1.41M |
|
711
Unity
U
$13.8B
| $2.49M | 0.01% |
78,026
+27,800
| +55% | +$1.14M |
|
712
Vaxcyte
PCVX
$7.67B
| $2.49M | 0.01% |
103,575
+28,665
| +38% | +$727K |
|
713
Baxter International
BAX
$12.8B
| $2.48M | 0.01% |
46,093
-2,695
| -6% | -$162K |
|
714
Voya Financial
VOYA
$9.02B
| $2.47M | 0.01% |
40,780
+17,305
| +74% | +$1.06M |
|
715
Aramark
ARMK
$15.2B
| $2.45M | 0.01% |
108,667
+14,321
| +15% | +$356K |
|
716
Deckers Outdoor
DECK
$13.9B
| $2.43M | 0.01% |
46,710
-6,720
| -13% | -$350K |
|
717
ITT
ITT
$17.4B
| $2.43M | 0.01% |
37,158
-7,460
| -17% | -$544K |
|
718
Microchip Technology
MCHP
$39.9B
| $2.41M | 0.01% |
39,477
+5,030
| +15% | +$330K |
|
719
Iovance Biotherapeutics
IOVA
$2.03B
| $2.41M | 0.01% |
251,371
+104,250
| +71% | +$1.2M |
|
720
Travere Therapeutics
TVTX
$5.12B
| $2.4M | 0.01% |
97,330
+20,431
| +27% | +$528K |
|
721
Chemed
CHE
$7.15B
| $2.39M | 0.01% |
5,476
-720
| -12% | -$346K |
|
722
Nutrien
NTR
$33.6B
| $2.39M | 0.01% |
26,239
-4,700
| -15% | -$404K |
|
723
Cameco
CCJ
$37.1B
| $2.39M | 0.01% |
+90,000
| New | +$2.3M |
|
724
Alcoa
AA
$11.4B
| $2.38M | 0.01% |
70,830
+22,410
| +46% | +$1.05M |
|
725
Donaldson
DCI
$10.8B
| $2.38M | 0.01% |
48,616
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.